Critical Analysis: Precipio (NASDAQ:PRPO) and MSP Recovery (NASDAQ:MSPR)

MSP Recovery (NASDAQ:MSPRGet Free Report) and Precipio (NASDAQ:PRPOGet Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, dividends, profitability, institutional ownership, analyst recommendations and risk.

Earnings and Valuation

This table compares MSP Recovery and Precipio”s gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
MSP Recovery $9.81 million 0.02 -$360.50 million ($572.83) -0.00
Precipio $24.05 million 1.86 -$360,000.00 ($0.47) -53.04

Precipio has higher revenue and earnings than MSP Recovery. Precipio is trading at a lower price-to-earnings ratio than MSP Recovery, indicating that it is currently the more affordable of the two stocks.

Insider & Institutional Ownership

3.8% of MSP Recovery shares are owned by institutional investors. Comparatively, 10.4% of Precipio shares are owned by institutional investors. 50.5% of MSP Recovery shares are owned by company insiders. Comparatively, 16.6% of Precipio shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Profitability

This table compares MSP Recovery and Precipio’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
MSP Recovery -7,328.48% -326.80% -81.27%
Precipio -3.57% -6.73% -4.49%

Volatility & Risk

MSP Recovery has a beta of -2.38, indicating that its stock price is 338% less volatile than the S&P 500. Comparatively, Precipio has a beta of 1.27, indicating that its stock price is 27% more volatile than the S&P 500.

Analyst Ratings

This is a summary of current recommendations and price targets for MSP Recovery and Precipio, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
MSP Recovery 1 0 0 0 1.00
Precipio 1 0 0 0 1.00

Summary

Precipio beats MSP Recovery on 9 of the 11 factors compared between the two stocks.

About MSP Recovery

(Get Free Report)

MSP Recovery, Inc. engages in the development of healthcare recoveries and data analytics software. It also focuses on the identification and recoveries of improper payments made by Medicare, Medicaid, and commercial insurance spaces using data and analytics. The company was founded by John H. Ruiz, Frank C. Quesada, and Diana Diaz on July 8, 2014 and is headquartered in Miami, FL.

About Precipio

(Get Free Report)

Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels. It offers biomarker testing and clinical project services to bio-pharma customers. The company is based in New Haven, Connecticut.

Receive News & Ratings for MSP Recovery Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MSP Recovery and related companies with MarketBeat.com's FREE daily email newsletter.